Related Experiment Video

Updated: Aug 17, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Update on Hepatitis B and C Coinfection in HIV

Patrick Yachimski1, Raymond T Chung

  • 1GRJ 825, GI Unit, Massachusetts General Hospital, Boston, MA 02114, USA. rtchung@partners.org.

Current Infectious Disease Reports
|June 21, 2005
PubMed

Insights

Coinfection with hepatitis B (HBV) or C (HCV) viruses is common in HIV patients, potentially worsening liver disease. Managing these coinfections requires careful diagnosis and staging, despite challenges with treatment resistance.

Area of Science:

  • Hepatology and Infectious Diseases
  • Viral Hepatitis and HIV Coinfection Management

Background:

  • Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfections are prevalent in individuals with human immunodeficiency virus (HIV).
  • HIV-associated immunosuppression can accelerate the progression of chronic viral hepatitis, leading to severe liver disease.
  • Existing therapies for HBV or HCV monoinfection are used in HIV-coinfected patients, but face challenges.

Purpose of the Study:

  • To review the impact of HIV coinfection on chronic viral hepatitis.
  • To discuss therapeutic strategies and challenges in managing HBV/HCV coinfection in HIV patients.
  • To emphasize the importance of timely diagnosis and staging for effective management.

Main Methods:

  • Review of existing literature on HBV/HCV and HIV coinfection.
  • Analysis of therapeutic approaches and outcomes in coinfected patients.
  • Discussion of diagnostic and staging criteria relevant to coinfection.

Main Results:

  • HIV infection alters the natural course of chronic viral hepatitis, increasing the risk of advanced liver disease.
  • Viral resistance and suboptimal virologic response are significant concerns with current therapies in coinfected individuals.
  • Effective management hinges on accurate diagnosis and clinical staging of hepatitis infection.

Conclusions:

  • Management of HBV or HCV in HIV-coinfected patients requires specialized approaches.
  • Addressing viral resistance and optimizing treatment response are critical unmet needs.
  • Timely diagnosis and staging are essential for improving clinical outcomes in this population.

More Related Videos

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...